DIGOXIN tablet indications and usage: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{AK}}
{{CMG}}; {{AE}} {{AK}}


'''''For patient information about Digoxin immune fab, click [[Digoxin (patient information)|here]].'''''
'''''For patient information about Digoxin, click [[Digoxin (patient information)|here]].'''''


==1 INDICATIONS AND USAGE==
==1 INDICATIONS AND USAGE==

Revision as of 12:13, 28 February 2014

Digoxin
DIGOXIN injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
DIGOXIN tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

For patient information about Digoxin, click here.

1 INDICATIONS AND USAGE

1.1 Heart Failure in Adults

Digoxin Tablets, USP are indicated for the treatment of mild to moderateheart failure in adults. Digoxin Tablets, USP increase left ventricular ejection fractionand improve heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, Digoxin Tablets, USP should be used in combination with a diuretic and an angiotensin-converting enzyme (ACE) inhibitor..

1.2 Heart Failure in Pediatric Patients

Digoxin Tablets, USP increase myocardial contractility in pediatric patients with heart failure.

1.3 Atrial Fibrillation in Adults

Digoxin Tablets, USP are indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation.

References

http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41c16cff-b03e-405e-a617-d6f45d3ce2bd